Neurocrine Biosciences Inc Ratios

Ratios Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020
Profitability
Gross Margin 91.64%98.92%99.06%
EBT Margin -1,866.61%-36.37%44.38%3.65%-1,688.11%-466.03%-940.60%-950.28%4.84%5.91%
EBIT Margin -1,817.47%-40.96%43.82%2.72%-1,701.88%-475.77%-982.48%-875.74%8.18%9.17%
EBITDA Margin -1,817.47%-27.54%48.48%9.62%-1,578.73%-452.67%-936.21%-960.49%4.66%5.12%
Operating Margin -1,817.47%-40.96%43.82%2.72%-1,701.88%-475.77%-982.48%-875.74%8.18%9.17%
Net Margin -1,866.61%-36.37%44.38%3.65%-1,688.11%-466.03%-940.60%-950.28%4.68%4.70%
FCF Margin -1,799.19%148.14%-1.87%-68.24%-1,032.96%-201.67%-735.26%-675.14%16.98%16.79%20.81%
Efficiency
Inventory Average 5.94M14.08M22.65M
Assets Average 141.40M167.17M175.33M198.85M358.91M419.94M591.34M905.37M1,149.58M1,520.35M
Equity Average 11.65M39.71M107.23M137.39M164.55M316.58M369.67M343.51M426.45M558.83M881.55M
Invested Capital 3.95M29.31M62.67M158.06M123.51M211.38M426.44M315.73M889.64M998.26M1,154.40M1,126.20M
Asset Utilization Ratio 0.550.320.020.060.040.030.500.690.69
Leverage & Solvency
Interest Coverage Ratio -6.731.212.26
Debt to Equity 0.64
Debt Ratio 0.31
Equity Ratio 0.130.430.790.780.860.890.860.460.480.490.65
Times Interest Earned -6.731.212.26
Valuation
Enterprise Value 69.31M292.28M340.58M323.54M483.25M1,504.15M4,496.95M3,054.57M6,350.25M5,824.70M9,228.63M8,150.98M
Market Capitalization 106.64M419.15M469.68M496.56M628.99M1,697.96M4,876.14M3,361.92M6,866.18M6,475.61M9,899.13M8,955.18M
Return Ratios
Return on Sales -18.67%-0.36%0.44%0.04%-16.88%-4.66%-9.41%-9.50%0.05%0.05%
Return on Capital Employed 0.36%0.01%-0.30%-0.35%-0.28%-0.38%-0.24%0.05%0.12%
Return on Invested Capital 0.04%0.05%
Return on Assets 0.24%0.01%-0.28%-0.32%-0.26%-0.34%-0.24%0.02%0.03%
Return on Equity -1.05%0.87%0.02%-0.36%-0.39%-0.29%-0.38%-0.41%0.05%0.07%